News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche Diagnostics (ROG.VX), a World Leader in HIV Monitoring Tests, and ARK Diagnostics, Inc. Sign Letter of Intent to Commercialize ARK's HIV Drug Monitoring Products



12/6/2007 6:21:15 AM

SUNNYVALE, Calif.--(BUSINESS WIRE)--ARK Diagnostics, Inc. (“ARK”), and Roche Diagnostics signed a letter of intent to negotiate a collaboration agreement that would grant Roche distribution and commercialization rights for ARK’s anti-HIV drug monitoring products. “We are pleased to partner with Roche Diagnostics — a world leader in diagnostics — to leverage its distribution and marketing strengths to quickly get the anti-HIV drug monitoring products to market,” said Johnny Valdez, president of ARK Diagnostics. “Roche will be immediately selling and distributing our products worldwide.”

Read at BioSpace.com


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES